Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing cancer from returning or spreading in a study of high-risk melanoma patients.
NBC News health reporter Aria Bendix explains what happens next.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.nbcnews.com — the content belongs to NBC News.